Treatment With Obinutuzumab Leads To Worse Outcomes In Haematological Patients Diagnosed With Omicron Variant COVID‐19 – Wiley

AbstractThe SARS-CoV-2 Omicron variant is thought to cause less severe disease among the general population, but disease severity among at-risk populations is unknown. We performed a retrospective analysis using a matched cohort of United States veterans to compare the disease severity of subjects infected during Omicron and Delta predominant periods...

LONDON—GSK PLC and Sanofi SA reported promising trial results for their Covid-19 vaccine that showed the shot—developed to target the Beta strain of the virus—was particularly effective against the Omicron variant.The two companies said Friday that in a trial involving 13,000 adults, the vaccine demonstrated efficacy of 64.7% against symptomatic...

Author of the article: A nurse inoculates a man with a booster dose of vaccine against COVID-19 on Feb. 15, 2022. Photo by ALFREDO ESTRELLA / AFP NEW YORK — COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original...

REUTERS/Hannah BeierRegister now for FREE unlimited access to Reuters.comNEW YORK (Reuters) - COVID-19 vaccines this fall are likely to be based on the Omicron variant of the coronavirus rather than the original strain, although some experts suggest they may only offer significant benefits for older and immunocompromised people.Moderna, Pfizer and...

Please enable cookies. We are checking your browser... www.fiercepharma.com Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal...

Why do I have to complete a CAPTCHA? Completing the CAPTCHA proves you are a human and gives you temporary access to the web property. What can I do to prevent this in the future? If you are on a personal connection, like at home, you can run an anti-virus...